mots c and tirzepatide MOTS-c Peptide | Longevity & Metabolism MOTS-c: A promising mitochondrial-derived peptide

Tirzepatide is technically the combination of two different drugs: a glucagon-like peptide-1 (GLP-1) receptor agonist and a glucose-dependent insulinotropic polypeptide (GIP) receptor agonist. Because of this, Tirzepatide is also known as a dual GLP-1/GIP receptor agonist. These are both hormones that your system releases after you eat

D., Land, L

This information should be interpreted with a qualified healthcare provider to support more informed discussions about which mechanism may align with personal metabolic factors and tolerability expectationsnot to guarantee outcomes or replace clinical judgment

It binds to GIP receptors with high affinity (comparable to endogenous GIP), while exhibiting approximately 5-fold lower affinity for GLP-1 receptors compared to native GLP-1

Late reordering can leave you without medication during critical dosing windows, potentially disrupting appetite suppression timelines and weight loss progress